Biotech Stocks At 52-Week Highs - AMLX +63% With Phase 3 Data, VOGX +25%, OBIO +19%, ATRC, CRLrttnews·Aug 19 at 03:26 AMAMLX-2.52%OBIO-1.29%
AtriCure Targets $1 Billion as Pain Management and AFib Trials Fuel GrowthMarket Beat·Aug 11 at 09:04 PMATRC+3.14%
ATRC: Strong growth, innovation, and clinical trial catalysts drive robust financial and market expansionQuartr·Aug 11 at 03:30 PMATRC+3.14%
AtriCure (NASDAQ:ATRC) Sets New 12-Month High - Here's WhyMarket Beat·Aug 11 at 03:20 PMATRC+3.14%BLK+1.47%
AtriCure Chief Scientific Officer Vinayak Doraiswamy disposes of $233,280 in common sharesPUBT·Jul 30 at 04:13 PMATRC+3.14%
Top 3 Health Care Stocks That May Implode This Monthbenzinga_article·Jul 29 at 07:45 AMTHC+3.00%ATRC+3.14%
Atricure Still Faces Broad, Evolving Risks Despite No Material Changes in 2025 10-K DisclosuresTip Ranks·Jul 28 at 01:00 AMATRC+3.14%
AtriCure, Inc. 2026: Revenue $153.6M, EPS $0.18— 10-Q SummaryTradingView·Jul 27 at 12:11 PMATRC+3.14%
AtriCure Q2 net income turns to USD 8.96 million; revenue rises 12.8% to USD 153.6 million year over yearPUBT·Jul 27 at 12:08 PMATRC+3.14%
Inspire Medical Systems appoints AtriCure CEO Michael Carrel to boardPUBT·Jul 27 at 07:06 AMATRC+3.14%INSP+1.78%
AtriCure to join Needham Virtual MedTech & Diagnostics investor conferencePUBT·Jul 27 at 07:00 AMATRC+3.14%
